Saturday 17 October 2026 Export CRSP’s income statement to Excel — free account

CRISPR Therapeutics AG

CRISPR Therapeutics AG’s revenue for fiscal 2025 (year ended December 2025) was $3.5 million, down 90.6% from fiscal 2024. In the quarter to June 2026, revenue grew 1,041.4%, EPS grew 60.8% and free cash flow grew 26.2%, each against the same quarter a year earlier.

49.30 2.22 −4.31%

Follow CRSP

Alert me

Market cap: $5.0B
P/E: 0.0×
Fwd P/E: −10.8×
Dividend yield: —
F-score: 2/9
Altman Z: 7.04
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	—	2	2	3
ROE Full definition →		(25.33%)	(30.18%)	(31.21%)	(26.09%)
ROA Full definition →		(21.70%)	(25.81%)	(23.24%)	(19.28%)
ROIC Full definition →		(131,984.38%)	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(25.29%)	(29.79%)	(23.45%)	(19.22%)
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(3.32)	(3.85)	(4.18)	(3.85)
Free Cash Flow Full definition →		(303.14)	(345.93)	(401.18)	(371.32)
Capital Expenditures Full definition →		(0.65)	(0.91)	(1.21)	(1.74)
Other line items
Cash ROIC Full definition →		(7.91%)	(8.88%)	(8.29%)	(7.91%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.01	0.01	0.01	0.01
Research and Development Expense of Revenue Full definition →		963.23%	10,856.38%	9,192.03%	2,095.48%
Selling, General and Administrative Expense of Revenue Full definition →		191.11%	2,095.21%	1,740.90%	523.19%
Share Based Compensation of Revenue Full definition →		199.21%	2,065.50%	1,672.22%	510.16%
Operating CF/Net income Full definition →		0.62	0.59	0.70	0.82
Depreciation/Fixed assets Full definition →		0.15	0.17	0.17	0.17
Capex/Depreciation Full definition →		(0.03)	(0.05)	(0.06)	(0.09)
Revenue per Share Full definition →		0.42	0.04	0.04	0.14
Operating CF per Share Full definition →		(3.31)	(3.84)	(4.16)	(3.83)
Capex per Share Full definition →		(0.01)	(0.01)	(0.01)	(0.02)
Capex to Sales Full definition →		0.02	0.26	0.30	0.13

Show all line items

Columns are period end dates

Stockrow Weekly